View Cart
Global Information, Inc.
US:
+1-860-674-8796
EU:
+32-2-535-7543
SG:
+65-6223-2436
Home
|
Category
|
Publishers
|
Custom Research
|
E-mail Alert
|
About Us
|
Contact Us
|
Site Map
|
Pharmaceutical
Drug Discovery
Drug Delivery System
Veterinary Medicine
Bone Disease Treatment
Obesity Treatment
Generic Drugs
OTC Drug
Prescription Drugs
Vaccines
Regulation
Cancer
Diabetes
Infection Disease
Mental Disease
Pharmaceutical Companies
Neurodegenerative Disease
View All Categories
Home
>
Category
>
Pharmaceutical
>
Market Research Report
US Launch: Phase IIIa, Phase IIIb and Launch Year Brand Commercialization
Published by
Cutting Edge Information
Published
2007/02
Content info
189 Pages
Product code
CEI47987
Price
From
US $ 7695
US $ 7695
PDF by E-mail (Single User License)
US $ 15995
PDF by E-mail (Multi User License)
How to Order?
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Charts and Graphics
EXECUTIVE SUMMARY
Figure E.1: Spending by Major Category
Figure E.2: Major Categories as a Percentage of Total Spending
Figure E.3: Market Research as a Percentage of Phase IIIa Spending
Figure E.4: Market Research as a Percentage of Phase IIIb Spending
Figure E.5: Market Research as a Percentage of Launch Year Spending
Figure E.6: Phase by Phase Major Categories as a Percentage of Total Spending
Figure 1.1: Brand 1 Dashboard
BRAND 1
Figure 1.1: Brand 1 Dashboard
Brand 1 Introduction
Figure 1.2: Brand 1 Total Commercialization Spend by Phase
Table 1.1: Brand 1 Total Spending by Category
Table 1.2: Brand 1 Advertising and Promotion Spending by Time Period
Table 1.3: Brand 1 Medical Affairs Spending by Time Period
Table 1.4: Brand 1 Decision Support Spending by Time Period
Table 1.5: Brand 1 Market Access Spending by Time Period
Phase IIIa Resources
Figure 1.3: Brand 1 Phase IIIa Spending
Figure 1.4: Brand 1 Phase IIIa Spending % Breakdown
Phase IIIb Resources
Figure 1.5: Brand 1 Phase IIIb Spending
Figure 1.6: Brand 1 Phase IIIb Spending % Breakdown
Launch Resources
Figure 1.7: Brand 1 Launch Spending
Figure 1.8: Brand 1 Launch Spending % Breakdown
Figure 1.9: Brand 1 Detail Aids Spending
Figure 1.10: Brand 1 Samples Spending
Figure 1.11: Brand 1 Journal Ads
Figure 1.12: Brand 1 Patient Education Spending
Figure 1.13: Brand 1 Speakers Spending
Figure 1.14: Brand 1 Thought Leader Development Spending
Figure 1.15: Brand 1 Thought Leader Programs Spending
Figure 1.16: Brand 1 Medical Education Spending
Figure 1.17: Brand 1 Medical Information Spending
Figure 1.18: Brand 1 Market Research Spending
Figure 1.19: Brand 1 Pricing Spending
Figure 1.20: Brand 1 Reimbursement Spending
BRAND 2
Figure 2.1: Brand 2 Dashboard
Brand 2 Introduction
Figure 2.2: Brand 2 Total Commercialization Spend by Phase
Table 2.1: Brand 2 Total Spending by Category
Table 2.2: Brand 2 Advertising and Promotion Spending by Time Period
Table 2.3: Brand 2 Medical Affairs Spending by Time Period
Table 2.4: Brand 2 Decision Support Spending by Time Period
Table 2.5: Brand 2 Market Access Spending by Time Period
Phase IIIb Resources
Figure 2.3: Brand 2 Phase IIIb Spending
Figure 2.4: Brand 2 Phase IIIb Spending % Breakdown
Launch Resources
Figure 2.5: Brand 2 Launch Spending
Figure 2.6: Brand 2 Launch Spending % Breakdown
Figure 2.7: Brand 2 Detail Aids Spending
Figure 2.8: Brand 2 Samples Spending
Figure 2.9: Brand 2 Journal Ads
Figure 2.10: Brand 2 Patient Education Spending
Figure 2.11: Brand 2 DTC Spending
Figure 2.12: Brand 2 Speakers Spending
Figure 2.13: Brand 2 Thought Leader Development Spending
Figure 2.14: Brand 2 Thought Leader Programs Spending
Figure 2.15: Brand 2 Medical Education Spending
Figure 2.16: Brand 2 Medical Information Spending
Figure 2.17: Brand 2 Market Research Spending
Figure 2.18: Brand 2 Competitive Intelligence Spending
Figure 2.19: Brand 2 Pricing Spending
Figure 2.20: Brand 2 Pharmacoeconomics Spending
Figure 2.21: Brand 2 Reimbursement Spending
BRAND 3
Figure 3.1: Brand 3 Dashboard
Brand 3 Introduction
Figure 3.2: Brand 3 Total Commercialization Spend by Phase
Table 3.1: Brand 3 Total Spending by Category
Table 3.2: Brand 3 Advertising and Promotion Spending by Time Period
Table 3.3: Brand 3 Medical Affairs Spending by Time Period
Table 3.4: Brand 3 Decision Support Spending by Time Period
Table 3.5: Brand 3 Market Access Spending by Time Period
Phase IIIb Resources
Figure 3.3: Brand 3 Phase IIIb Spending
Figure 3.4: Brand 3 Phase IIIb Spending % Breakdown
Launch Resources
Figure 3.5: Brand 3 Launch Year Spending
Figure 3.6: Brand 3 Launch Year Spending % Breakdown
Figure 3.7: Brand 3 Detail Aids Spending
Figure 3.8: Brand 3 Samples Spending
Figure 3.9: Brand 3 Journal Ads
Figure 3.10: Brand 3 Patient Education Spending
Figure 3.11: Brand 3 DTC Spending
Figure 3.12: Brand 3 Speakers Spending
Figure 3.13: Brand 3 Thought Leader Development Spending
Figure 3.14: Brand 3 Thought Leader Programs Spending
Figure 3.15: Brand 3 Medical Education Spending
Figure 3.16: Brand 3 Medical Information Spending
Figure 3.17: Brand 3 Market Research Spending
Figure 3.18: Brand 3 Competitive Intelligence Spending
Figure 3.19: Brand 3 Pricing Spending
Figure 3.21: Brand 3 Reimbursement Spending
Figure 3.20: Brand 3 Pharmacoeconomics Spending
BRAND 4
Figure 4.1: Brand 4 Dashboard
Brand 4 Introduction
Figure 4.2: Brand 4 Total Commercialization Spend by Phase
Table 4.1: Brand 4 Total Spending by Category
Table 4.2: Brand 4 Advertising and Promotion Spending by Time Period
Table 4.3: Brand 4 Medical Affairs Spending by Time Period
Table 4.4: Brand 4 Decision Support Spending by Time Period
Table 4.5: Brand 4 Market Access Spending by Time Period
Phase IIIa Resources
Figure 4.3: Brand 4 Phase IIIa Spending
Figure 4.4: Brand 4 Phase IIIa Spending % Breakdown
Phase IIIb Resources
Figure 4.5: Brand 4 Phase IIIb Spending
Figure 4.6: Brand 4 Phase IIIb Spending % Breakdown
Launch Resources
Figure 4.7: Brand 4 Launch Spending
Figure 4.8: Brand 4 Launch Spending % Breakdown
Figure 4.9: Brand 4 Detail Aids Spending
Figure 4.10: Brand 4 Journal Ads
Figure 4.11: Brand 4 Patient Education Spending
Figure 4.12: Brand 4 DTC Spending
Figure 4.13: Brand 4 Speakers Spending
Figure 4.14: Brand 4 Thought Leader Development Spending
Figure 4.15: Brand 4 Thought Leader Programs Spending
Figure 4.16: Brand 4 Medical Education Spending
Figure 4.17: Brand 4 Medical Information Spending
Figure 4.18: Brand 4 Market Research Spending
Figure 4.19: Brand 4 Competitive Intelligence Spending
Figure 4.20: Brand 4 Pricing Spending
Figure 4.21: Brand 4 Pharmacoeconomics Spending
Figure 4.22: Brand 4 Reimbursement Spending
BRAND 5
Figure 5.1: Brand 5 Dashboard
Brand 5 Introduction
Figure 5.2: Brand 5 Total Commercialization Spend by Phase
Table 5.1: Brand 5 Total Spending by Category
Table 5.2: Brand 5 Advertising and Promotion Spending by Time Period
Table 5.3: Brand 5 Medical Affairs Spending by Time Period
Table 5.4: Brand 5 Decision Support Spending by Time Period
Table 5.5: Brand 5 Market Access Spending by Time Period
Launch Year Resources
Figure 5.3: Brand 5 Launch Year Spending
Figure 5.4: Brand 5 Launch Year Spending % Breakdown
Figure 5.5: Brand 5 Detail Aids Spending
Figure 5.6: Brand 5 Samples Spending
Figure 5.7: Brand 5 Journal Ads
Figure 5.8: Brand 5 Patient Education Spending
Figure 5.9: Brand 5 DTC Spending
Figure 5.10: Brand 5 Speakers Spending
Figure 5.11: Brand 5 Thought Leader Development Spending
Figure 5.12: Brand 5 Thought Leader Programs Spending
Figure 5.13: Brand 5 Medical Education Spending
Figure 5.14: Brand 5 Medical Information Spending
Figure 5.15: Brand 5 Market Research Spending
Figure 5.16: Brand 5 Competitive Intelligence Spending
Figure 5.17: Brand 5 Pricing Spending
Figure 5.18: Brand 5 Pharmacoeconomics Spending
Figure 5.19: Brand 5 Reimbursement Spending
Brand 6
Figure 6.1: Brand 1 Dashboard
Brand 6 Introduction
Figure 6.2: Brand 1 Total Commercialization Spend by Phase
Table 6.1: Brand 6 Total Spending by Category
Table 6.2: Brand 6 Advertising and Promotion Spending by Time Period
Table 6.3: Brand 6 Medical Affairs Spending by Time Period
Table 6.4: Brand 6 Decision Support Spending by Time Period
Table 6.5: Brand 6 Market Access Spending by Time Period
Phase IIIa Resources
Figure 6.3: Brand 6 Phase IIIa Spending
Figure 6.4: Brand 6 Phase IIIa Spending % Breakdown
Phase IIIb Resources
Figure 6.5: Brand 6 Phase IIIb Spending
Figure 6.6: Brand 6 Phase IIIb Spending % Breakdown
Launch Year Resources
Figure 6.7: Brand 6 Phase IIIb Spending
Figure 6.8: Brand 6 Phase IIIb Spending % Breakdown
Figure 6.9: Brand 6 Detail Aids Spending
Figure 6.10: Brand 6 Samples Spending
Figure 6.11: Brand 6 Journal Ads
Figure 6.12: Brand 1 Patient Education Spending
Figure 6.13: Brand 6 DTC Spending
Figure 6.14: Brand 6 Speakers Spending
Figure 6.15: Brand 6 Thought Leader Development Spending
Figure 6.16: Brand 6 Thought Leader Programs Spending
Figure 6.17: Brand 6 Medical Education Spending
Figure 6.18: Brand 6 Medical Information Spending
Figure 6.19: Brand 6 Market Research Spending
Figure 6.20: Brand 6 Competitive Intelligence Spending
Figure 6.21: Brand 6 Pricing Spending
Figure 6.22: Brand 6 Pharmacoeconomics Spending
Figure 6.23: Brand 6 Reimbursement Spending
SURVEY DATA: ADVERTISING AND PROMOTION SPENDING
Figure 7.1: Advertising and Promotion Spending by Year
Figure 7.2: Breakdown of Advertising and Promotion Spending
Figure 7.3: Advertising and Promotion Spending: Detail Aids
Figure 7.4: Breakdown of Detail Aids Spending
Figure 7.5: Advertising and Promotion Spending: Samples
Figure 7.6: Breakdown of Samples Spending
Figure 7.7: Advertising and Promotion Spending: Journal Ads
Figure 7.8: Breakdown of Journal Ads Spending
Figure 7.9: Advertising and Promotion Spending: Patient Education
Figure 7.10: Breakdown of Patient Education Spending
Figure 7.11: Advertising and Promotion Spending: DTC
Figure 7.12: Breakdown of DTC Spending
Figure 7.13: Advertising and Promotion Spending: Speakers
Figure 7.14: Breakdown of Speakers Spending
SURVEY DATA: MEDICAL AFFAIRS
Figure 8.1: Medical Affairs Spending by Year
Figure 8.2: Breakdown of Medical Affairs Spending
Figure 8.3: Medical Affairs Spending: Thought Leader Development
Figure 8.4: Breakdown of Thought Leader Development Spending
Figure 8.5: Medical Affairs Spending: Thought Leader Programs
Figure 8.6: Breakdown of Thought Leader Programs Spending
Figure 8.7: Medical Affairs Spending: Medical Education
Figure 8.8: Breakdown of Medical Education Spending
Figure 8.9: Medical Affairs Spending: Medical Information
Figure 8.10: Breakdown of Medical Information Spending
SURVEY DATA: DECISION SUPPORT
Figure 9.1: Decision Support Spending by Year
Figure 9.2: Breakdown of Decision Support Spending
Figure 9.3: Decision Support Spending: Market Research
Figure 9.4: Breakdown of Market Research Spending
Figure 9.5: Decision Support Spending: Competitive Intelligence
Figure 9.6: Breakdown of Competitive Intelligence Spending
SURVEY DATA: MARKET ACCESS
Figure 10.1: Market Access Spending by Year
Figure 10.2: Breakdown of Market Access Spending
Figure 10.3: Market Access Spending: Pricing
Figure 10.4: Breakdown of Pricing Spending
Figure 10.6: Breakdown of Pharmacoeconomics Spending
Figure 10.5: Market Access Spending: Pharmacoeconomics
Figure 10.7: Market Access Spending: Reimbursement
Figure 10.8: Breakdown of Reimbursement Spending
Related Report
Eisai: Pipeline, Products, Performance, Potential
King Pharmaceuticals Inc.: PharmaVitae Profile
Les Laboratoires Servier: PharmaVitae Profile
Novartis: Pipeline, Products, Performance, Potential
Optimizing Lifecycle Management: Maximizing commercial lifespan through label expansion and combination products
Please inform me when related publications are released
US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.